Visionary Research

Abraxis BioScience, LLC is driving the discovery, research, and development, from bench-to-clinic, of new products and innovative core technologies that improve the lives of critically ill patients. A key priority is to leverage and exploit the potential for Abraxis' nab™ tumor-targeting technology, while continuing the discovery and development of new products. Abraxis relies on its rich research heritage, with extensive multifunctional chemistry capabilities, and its seasoned clinical development and regulatory experts to accelerate clinical proofs-of-principle leading to next-generation technology discoveries.